Visit us at WHX Dubai (Formerly Arab Health) Booth No. N21.L91 Dubai Exhibition Centre, Dubai 9–12 February 2026 Visit us at WHX Dubai (Formerly Arab Health) Booth No. N21.L91 Dubai Exhibition Centre, Dubai 9–12 February 2026 Visit us at WHX Dubai (Formerly Arab Health) Booth No. N21.L91 Dubai Exhibition Centre, Dubai 9–12 February 2026 Visit us at WHX Dubai (Formerly Arab Health) Booth No. N21.L91 Dubai Exhibition Centre, Dubai 9–12 February 2026 Visit us at WHX Dubai (Formerly Arab Health) Booth No. N21.L91 Dubai Exhibition Centre, Dubai 9–12 February 2026 Visit us at WHX Dubai (Formerly Arab Health) Booth No. N21.L91 Dubai Exhibition Centre, Dubai 9–12 February 2026 Visit us at WHX Dubai (Formerly Arab Health) Booth No. N21.L91 Dubai Exhibition Centre, Dubai 9–12 February 2026

Haemodialysis Concentrate Solutions & Dry Powder

Precision-formulated for consistent patient care

Renasol

This was the first product our company launched in 1987. It is robust and effective and still going strong. It is ready to use and makes for a safe and effective dialysis procedure. It meets the standard of the British Pharmacopoeia.

Compositions Available:

  • Bicarbonate concentrate with & without dextrose
  • Calcium-free bicarbonate concentrate
  • Potassium-free bicarbonate concentrate
  • Citrate concentrate

Packaging:

Sold in 5-litre and 10-litre canisters, with packets of bicarbonate powder.

Shelf Life:

36 months from the date of manufacture

Dry Citracon

Dry Citracon is a citrate based haemodialysis concentrate in powder form.

Compositions Available:

  • Dry Citracon with and without Dextrose
  • Dry Citracon Potassium-free
  • Dry Citracon Calcium-free

Packaging:

Acid concentrate is sold with the bicarbonate concentrate in an aluminium foil packaging for 10 dialysis.

Shelf Life:

36 months from the date of manufacture

Why we introduced Dry Citracon in the market?

Major Hospitals and Dialysis Centers used to use the acid concentrate required for Haemodialysis, which we refer to as Part A in liquid form. The base part (which we refer to as Part B) has to be in powder form because it is unstable in liquid form and has to be used by the patient within 6–8 hours of conversion to liquid form (by adding RO water) at the place of use.

After talking to representatives of various hospitals and dialysis centers around the world we realized that storage was a big issue. Lack of storage in these facilities meant that they could not stock supply as per the requirement of the patients. Their inventory finished very fast and they would not have supply to last even the lead time of the delivery schedules.

So we came up with the Dry Citracon. Since powder is easy and cheap to transport as opposed to liquid which is expensive and cumbersome.

We even pass the cost saving on transport & canisters to the centers, significantly reducing cost per dialysis, while ensuring quality of the same or even greater order as compared to the liquid form of the acid concentrate.

Dry Citracon also reduces heparin consumption by up to 45%, reduces inflammation in patients and can be used on patients with liver failure.

Advantages:

  • Reduces Heparin consumption up to 45%, thus eliminating almost half the heparin cost
  • Very effective in heparin free dialysis since it is a known anti-coagulant
  • Dialyzer reuse increases up to 30%
  • Increases dialysis dose Kt/V and URR
  • Reduces heparin related complications viz. Osteoporosis, Pruritus, disturbed Lipid Metabolism etc
  • Elimination of acetate related complications
  • Reduced inflammation
  • Can be used with patients suffering from liver failure
  • Reducing metabolic acidosis

Compare the difference

Liquid concentrate

  • Space required for 1000 lit. Liquid Conc. 15" × 90" × 70"
  • Transportation expensive
  • 52 purchase orders
  • 52 deliveries per year

Dry Citracon

  • Space required for 1000 lit. Dry Conc. 28" × 24" × 14"
  • Saving 90% space
  • Transportation – easy and cost is negligible
  • 12 purchase orders per year
  • 12 deliveries per year

50,000

Serve over 50,000 patients per year

5 million

assist in over 5 million dialysis treatments per year

Partner with us to shape the future of dialysis care.

Our Clients